Inclusion or Exclusion of Intratumoral Vessels in Relative Cerebral Blood Volume Characterization in Low-Grade Gliomas: Does It Make a Difference?
Gisele Brasil Caseiras(National Hospital for Neurology and Neurosurgery), Hans Rolf Jäger(National Hospital for Neurology and Neurosurgery), John S. Thornton(University College London), Christopher E. Benton(National Hospital for Neurology and Neurosurgery), Adam Waldman(Royal Society of Edinburgh), Tarek Yousry(National Hospital for Neurology and Neurosurgery), Jeremy Rees(National Hospital for Neurology and Neurosurgery)
Cited by 27
Related Papers
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
|New England Journal of Medicine|2006|792
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|The Lancet Neurology|2022|651
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646